Opioid Use Disorder Clinical Trials

A listing of Opioid Use Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 193 clinical trials
Buprenorphine Loading in the Emergency Department

Buprenorphine (BUP) is FDA-approved for the treatment of opioid withdrawal and opioid use disorder. Few ED providers have received the necessary DEA registration (aka X waiver) required to

  • 01 Feb, 2021
  • 1 location
reSET-O RCT (Randomized Controlled Trial)

This randomized controlled trial research study will be evaluating an app, reSET-O, owned by Pear Therapeutics, Inc., to evaluate treatment retention rates in individuals with opioid use

  • 26 Jan, 2021
  • 1 location
Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery

This study is designed as an open-label evaluation of how treatment with XR-NTX may influence the quality and speed of recovery of opioid dependent individuals - in a context of a naturalistic clinical treatment of opioid dependence. The study will assess recovery outcomes and compare these with the clinical effectiveness …

  • 23 Jan, 2021
  • 1 location
Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Despite the demonstrated effectiveness of agonist treatment for opioid dependence and alarming recent increases in overdose deaths, waiting lists for treatment persist. In a Behavioral & Integrative Treatment Development pilot study, the investigators demonstrated the initial efficacy a novel Interim Buprenorphine Treatment (IBT) to mitigate the risks (e.g., illicit opioid …

  • 22 Jan, 2021
  • 1 location
Transforming Recovery Through Exercise and Community

The primary aim of this study is to develop a feasible, acceptable, and effective multilevel physical activity (PA) intervention that addresses both individual and interpersonal factors that can be easily scalable and delivered in the context of a methadone clinic. To do so, the investigators will train methadone maintenance treatment …

  • 02 Jun, 2021
  • 1 location
Medication Maintenance Therapy in Community Pharmacy Settings

The goal of this study is to compare pharmacy-based medication assisted treatment (MAT) with usual care MAT for people with opioid use disorder.

  • 23 Jan, 2021
Digital Health Intervention for Medication-Assisted Treatment

Medication-assisted treatment, including buprenorphine, is a first-line treatment for opioid use disorders; however, despite its many advantages, nearly 50% of patients are unable to achieve stabilization and long-term recovery. The proposed study will test whether a computer- and text message-delivered intervention can promote engagement in and adherence to buprenorphine among …

  • 26 Jan, 2021
  • 1 location
Contingency Management to Enhance Office-Based Buprenorphine Treatment

opioid use disorder. Participants (N=375) will be randomly assigned to one of the three groups. Buprenorphine Adherence and Opiate Abstinence and Buprenorphine Adherence Only participants will receive

  • 17 Feb, 2021
  • 1 location
Facilitating the Implementation of Interim Methadone to Increase Treatment Access

The primary aim of this study is to evaluate the effectiveness of Implementation Facilitation (IF) in promoting increased accessibility to methadone treatment.

  • 25 Jan, 2021
  • 1 location
Response to Relapse in Office-Based Opioid Treatment Trial

In a sample of individuals with co-occurring OUD and mental disorders, the investigators plan to test two medications for opioid use disorder (MOUD) treatment protocols that involve differing

  • 24 Jan, 2021